Insulin-like growth factor-I and -II levels are associated with the progression of nonalcoholic fatty liver disease in obese children

Journal of Pediatrics

Volumn 165, Issue 1, 2014, Pages 92-98

  Cianfarani, Stefano ^a,b   Inzaghi, Elena ^a   Alisi, Anna ^c   Germani, Daniela ^d   Puglianiello, Antonella ^d   Nobili, Valerio ^c  

^a TOR VERGATA UNIVERSITY HOSPITAL   (Italy)

^b KAROLINSKA INSTITUTE   (Sweden)

^c BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^d UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; C REACTIVE PROTEIN; GAMMA GLUTAMYLTRANSFERASE; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; TRIACYLGLYCEROL;

ANTHROPOMETRY; ARTICLE; CARDIOMETABOLIC RISK; CHILD; CHILDHOOD OBESITY; CHOLESTEROL BLOOD LEVEL; CROSS-SECTIONAL STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; HUMAN; LIPID ANALYSIS; LIVER BIOPSY; MALE; NONALCOHOLIC FATTY LIVER; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCHOOL CHILD; SCORING SYSTEM;

BIOLOGICAL MARKERS; BIOPSY; CHILD; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; FATTY LIVER; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; LIVER; MALE; PEDIATRIC OBESITY; REGRESSION ANALYSIS;

EID: 84903391992     PISSN: 00223476     EISSN: 10976833     Source Type: Journal    
DOI: 10.1016/j.jpeds.2014.01.052     Document Type: Article

References (52)

1. J.I. Jones, and D.R. Clemmons Insulin-like growth factors and their binding proteins: biological actions Endocr Rev 16 1995 3 34
2. D.R. Clemmons Role of insulin-like growth factor in maintaining normal glucose homeostasis Horm Res 62 Suppl 1 2004 77 82
3. D. LeRoith, and S. Yakar Mechanisms of disease: metabolic effects of growth hormone and insulin-like growth factor 1 Nat Clin Pract Endocrinol Metab 3 2007 302 310
4. A. Alisi, S. Cianfarani, M. Manco, C. Agostoni, and V. Nobili Non-alcoholic fatty liver disease and metabolic syndrome in adolescents: pathogenetic role of genetic background and intrauterine environment Ann Med 44 2012 29 40
5. A. Alisi, G. Carpino, and V. Nobili Paediatric nonalcoholic fatty liver disease Curr Opin Gastroenterol 29 2013 279 284
6. T. Ichikawa, K. Hamasaki, H. Ishikawa, E. Ejima, K. Eguchi, and K. Nakao Non-alcoholic steatohepatitis and hepatic steatosis in patients with adult-onset growth hormone deficiency [letter] Gut 52 2003 914
7. H. Nishizawa, G. Iguchi, A. Murawaki, H. Fukuoka, Y. Hayashi, and H. Kaji et al. Nonalcoholic fatty liver disease in adult hypopituitary patients with GH deficiency and the impact of GH replacement therapy Eur J Endocrinol 167 2012 67 74
8. L.A. Adams, A. Feldstein, K.D. Lindor, and P. Angulo Nonalcoholic fatty liver disease among patients with hypothalamic and pituitary dysfunction Hepatology 39 2004 909 914
9. Y. Takahashi, K. Iida, K. Takahashi, S. Yoshioka, H. Fukuoka, and R. Takeno et al. Growth hormone reverses nonalcoholic steatohepatitis in a patient with adult growth hormone deficiency Gastroenterology 132 2007 938 943
10. I. Fukuda, N. Hizuka, K. Yasumoto, J. Morita, M. Kurimoto, and K. Takano Metabolic comorbidities revealed in patients with childhood-onset adult GH deficiency after cessation of GH replacement therapy for short stature Endocr J 55 2008 977 984
11. A. Lonardo, P. Loria, F. Leonardi, D. Ganazzi, and N. Carulli Growth hormone plasma levels in nonalcoholic fatty liver disease Am J Gastroenterol 97 2002 1071 1072
12. T. Ichikawa, K. Nakao, K. Hamasaki, R. Furukawa, S. Tsuruta, and Y. Ueda et al. Role of growth hormone, insulin-like growth factor 1 and insulin-like growth factor-binding protein 3 in development of non-alcoholic fatty liver disease Hepatol Int 1 2007 287 294
13. D. Garcia-Galiano, M.A. Sanchez-Garrido, I. Espejo, J.L. Montero, G. Costan, and T. Marchal et al. IL-6 and IGF-1 are independent prognostic factors of liver steatosis and non-alcoholic steatohepatitis in morbidly obese patients Obes Surg 17 2007 493 503
14. M.L. Hribal, T. Procopio, S. Petta, A. Sciacqua, S. Grimaudo, and R.M. Pipitone et al. Insulin-like growth factor-I, inflammatory proteins, and fibrosis in subjects with nonalcoholic fatty liver disease J Clin Endocrinol Metab 98 2013 E304 E308
15. H. Nishizawa, M. Takahashi, H. Fukuoka, G. Iguchi, R. Kitazawa, and Y. Takahashi GH-independent IGF-I action is essential to prevent the development of nonalcoholic steatohepatitis in a GH-deficient rat model Biochem Biophys Res Commun 423 2012 295 300
16. S. Cianfarani Insulin-like growth factor II: new roles for an old actor Front Endocrinol (Lausanne) 3 2012 118
17. E. Perkins, S.K. Murphy, A.P. Murtha, J. Schildkraut, R.L. Jirtle, and W. Demark-Wahnefried et al. Insulin-like growth factor 2/H19 methylation at birth and risk of overweight and obesity in children J Pediatr 161 2012 31 39
18. A. Deodati, E. Inzaghi, A. Liguori, A. Puglianiello, D. Germani, and C. Brufani et al. IGF2 methylation is associated with lipid profile in obese children Horm Res Paediatr 14 2013 361 367
19. T.J. Cole, M.C. Bellizzi, K.M. Flegal, and W.H. Dietz Establishing a standard definition for child overweight and obesity worldwide: international survey BMJ 320 2000 1240 1243
20. E. Cacciari, S. Milani, A. Balsamo, E. Spada, G. Bona, and L. Cavallo et al. Italian cross-sectional growth charts for height, weight and BMI (2 to 20 yr) J Endocrinol Invest 29 2006 581 593
21. A. Tura, A. Kautzky-Willer, and G. Pacini Insulinogenic indices from insulin and C-peptide: comparison of beta-cell function from OGTT and IVGTT Diabetes Res Clin Pract 72 2006 298 301
22. N. Gungor, R. Saad, J. Janosky, and S. Arslanian Validation of surrogate estimates of insulin sensitivity and insulin secretion in children and adolescents J Pediatr 144 2004 47 55
23. M. Matsuda, and R.A. DeFronzo Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp Diabetes Care 22 1999 1462 1470
24. A.J. Sanyal, E.M. Brunt, D.E. Kleiner, K.V. Kowdley, N. Chalasani, and J.E. Lavine et al. Endpoints and clinical trial design for nonalcoholic steatohepatitis Hepatology 54 2011 344 353
25. C. Carter-Kent, L.M. Yerian, E.M. Brunt, P. Angulo, R. Kohli, and S.C. Ling et al. Nonalcoholic steatohepatitis in children: a multicenter clinicopathological study Hepatology 50 2009 1113 1120
26. D.E. Kleiner, E.M. Brunt, M. Van Natta, C. Behling, M.J. Contos, and O.W. Cummings et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease Hepatology 41 2005 1313 1321
27. E.M. Brunt, D.E. Kleiner, and L.A. Wilson Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings Hepatology 53 2011 810 820
28. V. Giorgio, F. Prono, F. Graziano, and V. Nobili Pediatric nonalcoholic fatty liver disease: old and new concepts on development, progression, metabolic insight and potential treatment targets BMC Pediatr 13 2013 40
29. Y. Higashi, S. Sukhanov, A. Anwar, S.Y. Shai, and P. Delafontaine IGF-1, oxidative stress and atheroprotection Trends Endocrinol Metab 21 2010 245 254
30. Y. Colak, E. Senates, O. Ozturk, Y. Yilmaz, E. Zemheri, and F. Yilmaz Enc et al. Serum concentrations of human insulin-like growth factor-1 and levels of insulin-like growth factor-binding protein-5 in patients with nonalcoholic fatty liver disease: association with liver histology Eur J Gastroenterol Hepatol 24 2012 255 261
31. V. Nobili, M. Marcellini, R. Devito, P. Ciampalini, F. Piemonte, and D. Comparcola et al. NAFLD in children: a prospective clinical-pathological study and effect of lifestyle advice Hepatology 44 2006 458 465
32. J.P. Thissen, and J. Verniers Inhibition by interleukin-1 beta and tumor necrosis factor-alpha of the insulin-like growth factor I messenger ribonucleic acid response to growth hormone in rat hepatocyte primary culture Endocrinology 138 1997 1078 1084
33. A.J. Varewijck, M.P. Brugts, J. Frystyk, J.A. Goudzwaard, P. Uitterlinden, and A.M. Waaijers et al. Circulating insulin-like growth factors may contribute substantially to insulin receptor isoform A and insulin receptor isoform B signalling Mol Cell Endocrinol 365 2013 17 24
34. M. Harrela, H. Koistinen, J. Kaprio, M. Lehtovirta, J. Tuomilehto, and J. Eriksson et al. Genetic and environmental components of interindividual variation in circulating levels of IGF-I, IGF-II, IGFBP-1, and IGFBP-3 J Clin Invest 98 1996 2612 2615
35. R.N. Rehem, and W.M. El-Shikh Serum IGF-1, IGF-2, and IGFBP-3 as parameters in the assessment of liver dysfunction in patients with hepatic cirrhosis and in the diagnosis of hepatocellular carcinoma Hepatogastroenterology 58 2011 949 954
36. L. Rossetti, N. Barzilai, W. Chen, T. Harris, D. Yang, and C.E. Rogler Hepatic overexpression of insulin-like growth factor-II in adulthood increases basal and insulin-stimulated glucose disposal in conscious mice J Biol Chem 271 1996 203 208
37. M. Garcia-Fernandez, I. Sierra, J.E. Puche, L. Guerra, and I. Castilla-Cortazar Liver mitochondrial dysfunction is reverted by insulin-like growth factor II (IGF-II) in aging rats J Transl Med 9 2011 123
38. R.C. Scarpa, R.E. Carraway, and D.E. Cochrane Insulin-like growth factor (IGF)-induced proliferation of human lung fibroblasts is enhanced by neurotensin Peptides 26 2005 2201 2210
39. M. Hetzel, M. Bachem, D. Anders, G. Trischler, and M. Faehling Different effects of growth factors on proliferation and matrix production of normal and fibrotic human lung fibroblasts Lung 183 2005 225 237
40. E. Hsu, and C.A. Feghali-Bostwick Insulin-like growth factor-II is increased in systemic sclerosis-associated pulmonary fibrosis and contributes to the fibrotic process via jun N-terminal kinase- and phosphatidylinositol-3 kinase-dependent pathways Am J Pathol 172 2008 1580 1590
41. S.D. O'Dell, G.J. Miller, J.A. Cooper, P.C. Hindmarsh, P.J. Pringle, and H. Ford et al. Apal polymorphism in insulin-like growth factor II (IGF2) gene and weight in middle-aged males Int J Obes Relat Metab Disord 21 1997 822 825
42. T.R. Gaunt, J.A. Cooper, G.J. Miller, I.N. Day, and S.D. O'Dell Positive associations between single nucleotide polymorphisms in the IGF2 gene region and body mass index in adult males Hum Mol Genet 10 2001 1491 1501
43. C. Le Stunff, D. Fallin, and P. Bougneres Paternal transmission of the very common class I INS VNTR alleles predisposes to childhood obesity Nat Genet 29 2001 96 99
44. D. Gu, S.D. O'Dell, X.H. Chen, G.J. Miller, and I.N. Day Evidence of multiple causal sites affecting weight in the IGF2-INS-TH region of human chromosome 11 Hum Genet 110 2002 173 181
45. W. Zhang, N. Maniatis, S. Rodriguez, G.J. Miller, I.N. Day, and T.R. Gaunt et al. Refined association mapping for a quantitative trait: weight in the H19-IGF2-INS-TH region Ann Hum Genet 70 2006 848 856
46. O. Ukkola, G. Sun, and C. Bouchard Insulin-like growth factor 2 (IGF2) and IGF-binding protein 1 (IGFBP1) gene variants are associated with overfeeding-induced metabolic changes Diabetologia 44 2001 2231 2236
47. M.A. Schrager, S.M. Roth, R.E. Ferrell, E.J. Metter, E. Russek-Cohen, and N.A. Lynch et al. Insulin-like growth factor-2 genotype, fat-free mass, and muscle performance across the adult life span J Appl Physiol 97 2004 2176 2183
48. T. Rice, Y.C. Chagnon, L. Perusse, I.B. Borecki, O. Ukkola, and T. Rankinen et al. A genomewide linkage scan for abdominal subcutaneous and visceral fat in black and white families: the HERITAGE family study Diabetes 51 2002 848 855
49. C. Maffeis, A. Pietrobelli, A. Grezzani, S. Provera, and L. Tato Waist circumference and cardiovascular risk factors in prepubertal children Obes Res 9 2001 179 187
50. P. Zimmet, K.G. Alberti, F. Kaufman, N. Tajima, M. Silink, and S. Arslanian et al. The metabolic syndrome in children and adolescents: an IDF consensus report Pediatr Diabetes 8 2007 299 306
51. M.K. Sinha, C. Buchanan, C. Raineri-Maldonado, P. Khazanie, S. Atkinson, and R. DiMarchi et al. IGF-II receptors and IGF-II-stimulated glucose transport in human fat cells Am J Physiol 258 1990 E534 E542
52. M.E. Haas, A.D. Attie, and S.B. Biddinger The regulation of ApoB metabolism by insulin Trends Endocrinol Metab 24 2013 391 397